SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm

By Benzinga1 day ago

PHILADELPHIA, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Decision Diagnostics Corp. (“Decision Diagnostics“) (OTC:DECN) on behalf of the company's stockholders.

On December 17, 2020, the U.S. Securities and Exchange Commission (“SEC“) filed a complaint against Decision Diagnostics and its Chief Executive Officer (“CEO“), Keith Berman, in the U.S. District Court for the Southern District of New York. The complaint alleges that Decision Diagnostics and Berman seized upon the Covid-19 global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test ...

Full story available on Benzinga.com

Continue read on benzinga.com